menoPAUSE: Mental Health as a Vital Sign
November 1, 2023
November 1, 2024
Menopause, Mental Health, Mood Disorders, Anxiety, Depression, Major Depression, Nutrition, Dementia
This activity is provided by Antidote Education Company and American College of Osteopathic Obstetricians and Gynecologists (ACOOG).
This activity is supported in part by an independent education grant from Astellas Pharma Global Development, Inc. and Pfizer Inc..
- Physicians — maximum of .75 AMA PRA Category 1 Credits™
- Nurses — .75 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This activity is designed to meet the educational needs of OB/GYN physicians, family medicine clinicians, internal medicine clinicians, other women’s health care providers (PAs, NPs) and patients in pre, peri, and late menopause.
Approximately 80% of women experience physical and/or psychological symptoms around menopause. Menopause can substantially affect mental health, which is underappreciated by many healthcare providers (HCPs) who attribute symptoms to stress, particularly for patients in perimenopause. Join Drs. Mary Jane Minkin, Mache Seibel, and Verna Brooks McKenzie who present cases of women going through the stages of menopause. The faculty summarize risk factors for menopause-related depression and examine treatment options and considerations.
Upon completion of this activity, participants should be better able to:
- Examine the effects of hormone therapy on depression in perimenopausal women.
- Describe the need for patient education on menopause.
- Recognize the relationship between mental health issues and menopause.
- Recognize racial disparities in menopausal symptoms and treatment.
- Recall the health-related outcomes associated with vasomotor symptoms in women in menopause.
- Describe patient characteristics that are associated with less benefit of hormone therapy for menopause.
Verna Brooks McKenzie, MD, PhD, NCMP
Touro University Medical Imaging Program
New York, NY
Mary Jane Minkin, MD, FACOG, MSCP
Department of Obstetrics, Gynecology, and Reproductive Sciences
Yale Medical School
New Haven, CT
Mache Seibel, MD
Menopause Expert, Speaker, Author
25-year Member Harvard Medical School
Beth Israel Deaconess Medical Center
Antidote Education Company is accredited with Commendation by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians: Antidote Education designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nurses: This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center's Commission on Accreditation. Nurses may receive a maximum of 0.75 contact hours.
Disclosure of Conflicts of Interest
- Verna Brooks McKenzie, MD, PhD, NCMP
- Advisory Board Member: Women’s Health Astellas Pharma. Relationships has ended.
- Mary Jane Minkin, MD, FACOG, MSCP
- Consultant: Astellas Pharma, Pfizer Inc., TherapeuticsMD, Inc., and Schaper & Brümmer
- Speaker: TherapeuticsMD, Inc.
- Relationships with TherapeuticsMD, Inc. as Consultant and Speaker have ended.
- Mache Seibel, MD
- Nothing to disclose.
All relevant financial relationships have been mitigated.
The following planners, content reviewer, and writer/editor have reported that they do not have any relevant financial relationships with ACCME-defined ineligible companies during the past 24 months: Andrew Crim, MEd, CHCP, FACEhp; Matthew Fleming; Michael Fleming, MD; Karen Giblin, Laura Irvin, MHL, RN, BSN; and Christine Welniak.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CE information and faculty disclosures.
2. Participate in the online activity
3. Complete the post-test with a score of 70% or better.
4. Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Antidote Education Company requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. This activity will not discuss any “off-label” substance(s)/product(s) not approved by the FDA.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions please contact Antidote Education Company [email protected]